Dupilumab yields larger improvements in lung function than several other biologics in patients with severe asthma.
Morning Overview on MSN
New seasonal allergy treatments show promise, but no cure yet
A string of FDA approvals and late-stage clinical trials has expanded the toolkit for treating seasonal and environmental allergies, giving patients new ways to manage symptoms and, in some cases, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results